SISanju Iwamoto

Sanju Iwamoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sanju Iwamoto has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Coexpression of CCR6 and CD146 (MCAM) is a marker of effector memory T‐helper 17 cells

    by Taisuke Kamiyama, Hideaki Watanabe, Masafumi Iijima, Akira Miyazaki, Sanju Iwamoto

    Effector memory T (TEM) cells are a subpopulation of memory T cells that express receptors mediating migration to inflamed tissues and produce various cytokines. Effector memory T‐helper (Th)17 (Th17EM) cells are thought to be essential for inflammation in Th17‐mediated diseases, but have not been studied in detail. To identify superior surface markers to isolate a homogeneous population of Th17EM cells from peripheral blood, CD4+ T cells were isolated from the peripheral blood of healthy donors based on the expression of CCR7, CCR6 and CD146 using six‐color flow cytometry. After 4 days of culture in the presence of anti‐CD3/28 beads, intracellular cytokines were determined by flow cytometric analysis. To investigate the relevance of Th17EM cells in Th17‐mediated disease, the frequencies of TEM‐cell subsets in psoriasis were quantified using six‐color flow cytometry. An enzyme‐linked immunosorbent assay was performed to confirm the interleukin (IL)‐17‐producing capacity of TEM‐cell subsets from the peripheral blood of a patient with psoriasis. CCR6+CD146+ TEM (CD4+CD45RA−CCR7−) cells had a greater capacity to produce IL‐17 than CCR6+CD146− or CCR6−CD146+ TEM cells. Although the percentage of CCR6+CD146+ cells in TEM cells was not significantly different between patients with psoriasis and controls, three of eight patients had a higher percentage of CCR6+CD146+ TEM cells than the mean +5 standard deviations of the controls. Coexpression of CCR6 and CD146 is a useful marker for Th17EM cells. Increasing the number of CCR6+CD146+ Th17EM cells in peripheral blood may facilitate estimation of systemic Th17‐cell activity in Th17‐mediated diseases.